Introduction Tirzepatide, a recently approved glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulin tropic polypeptide (GIP) dual agonist for the
Introduction Tirzepatide, a recently approved glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulin tropic polypeptide (GIP) dual agonist for the